cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Precision Biosciences Inc
12 own
15 watching
Current Price
$9.48
$0.08
(0.85%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
49.47M
52-Week High
52-Week High
21.90000
52-Week Low
52-Week Low
8.25000
Average Volume
Average Volume
0.06M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization49.47M
icon52-Week High21.90000
icon52-Week Low8.25000
iconAverage Volume0.06M
iconDividend Yield--
iconP/E Ratio--
What does the Precision Biosciences Inc do?
Precision BioSciences, Inc., a clinical stage gene editing company, develops vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. The company operates through two segments, Therapeutic and Food. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which a specific type of immune cell, called a T cell, is genetically engineered to recognize and kill cancer cells; PBCAR0191, which is in Phase 1/2a clinical trial in adult patients with R/R NHL or R/R B-cell precursor acute lymphoblastic leukemia, or B-ALL; PBCAR19B, an anti-CD19 CAR T candidate built on the stealth cell platform utilizing a single-step gene edit to minimize the risk of chromosome abnormalities; and PBCAR269A, an investigational allogeneic CAR T immunotherapy targeting BCMA for the treatment of R/R multiple myeloma. The company has development and commercial license agreement with Servier to develop allogeneic chimeric antigen receptor T cell therapies for antigen targets, hematological cancer targets beyond CD19, and solid tumor targets; Tiziana Life Sciences to evaluate foralumab, a fully human anti-CD3 monoclonal antibody as a lymphodepleting agent for the potential treatment of cancers; and iECURE, Inc. to develop ARCUS-based gene editing therapies. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.
Read More
How much money does Precision Biosciences Inc make?
News & Events about Precision Biosciences Inc.
Ticker Report
1 year ago
Precision BioSciences (NASDAQ:DTIL Get Rating) and Brainstorm Cell Therapeutics (NASDAQ:BCLI Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, ...
Benzinga
1 year ago
read more...
Business Wire
1 year ago
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced a promotion and organizational changes within the Companys Senior Leadership Team (SLT). The company announced the...
Business Wire
1 year ago
Precision BioSciences (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today reported on its significant accomplishments in 2022 and announced its corporate priorities and anticipated clinical development and...
Business Wire
1 year ago
Precision BioSciences (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that the U.S. Food and Drug Administration (FDA) provided supportive Type C feedback on the Companys CMC processes and...
Frequently Asked Questions
Frequently Asked Questions
What is Precision Biosciences Inc share price today?
plus_minus_icon
Can Indians buy Precision Biosciences Inc shares?
plus_minus_icon
How can I buy Precision Biosciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Precision Biosciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Precision Biosciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Precision Biosciences Inc?
plus_minus_icon
What is today’s market capitalisation of Precision Biosciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Precision Biosciences Inc?
plus_minus_icon
What percentage is Precision Biosciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Precision Biosciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$9.48
$0.08
(0.85%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00